Parameter | No-MS | WHO-MS | Surplus-MS (IDF) | ANOVA p |
---|---|---|---|---|
Frequency (n) | 50% (790) | 20% (314) | 30% (464) | Â |
Age (years) | 42 ± 13 | 47 ± 12a | 49 ± 13b | <0.001 |
BMI (kg/m2) | 27 ± 4 | 33 ± 5a | 31 ± 4b,c | <0.001 |
SBP (mmHg) | 124 ± 19 | 145 ± 22a | 142 ± 26b | <0.001 |
DBP(mmHg) | 80 ± 11 | 92 ± 12a | 90 ± 12b,c | <0.001 |
Glucose (mmol/l) | 4.8 ± 0.4 | 5.4 ± 0.6a | 5.0 ± 0.6b,c | <0.001 |
Log insulin (pmol/l) | 1.60 ± 0.22 | 2.01 ± 0.13a | 1.69 ± 0.17b,c | <0.001 |
Log HOMA-IR | 0.07 ± 0.23 | 0.53 ± 0.14a | 0.18 ± 0.18b,c | <0.001 |
Framingham risk score | 1.10 ± 1.87 | 2.99 ± 4.64a | 2.93 ± 4.54b | <0.001 |
Women: | Â | Â | Â | Â |
Frequency (n) | 51% (525) | 18% (191) | 31% (320) | Â |
Waist (cm) | 86.0 ± 11.4 | 102.8 ± 9.7a | 95.8 ± 9.5b,c | <0.001 |
TC (mmol/l) | 4.64 ± 1.06 | 4.99 ± 1.13a | 4.86 ± 1.00b | <0.001 |
HDL-C (mmol/l) | 1.36 ± 0.31 | 1.07 ± 0.26a | 1.09 ± 0.23b | <0.001 |
LDL-C (mmol/l) | 2.82 ± 0.92 | 3.06 ± 0.97a | 3.04 ± 0.85b | <0.001 |
Log TG (mmol/l) | -0.02 ± 0.16 | 0.23 ± 0.19a | 0.16 ± 0.19b,c | <0.001 |
Men: | Â | Â | Â | Â |
Frequency (n) | 50% (265) | 23% (123) | 27% (144) | Â |
Waist (cm) | 94.2 ± 9.8 | 107.0 ± 8.3a | 103.1 ± 6.0b,c | <0.001 |
TC (mmol/l) | 4.57 ± 0.93 | 4.89 ± 0.91a | 4.79 ± 0.94 | 0.004 |
HDL-C (mmol/l) | 1.08 ± 0.24 | 0.92 ± 0.22a | 0.92 ± 0.24b | <0.001 |
LDL-C (mmol/l) | 2.90 ± 0.82 | 2.90 ± 0.81 | 2.92 ± 0.84 | 0.957 |
Log TG (mmol/l) | 0.07 ± 0.19 | 0.32 ± 0.23a | 0.25 ± 0.22b,c | <0.001 |